Company intelligence / Profile preview

Deep Brain Innovations

Cleveland, Ohio, United Statesotc.duke.edu ↗

Ownership: Private
Development stage: Commercial

Overview

Deep Brain Innovations has developed the TOPS DBS, a next-generation deep brain stimulation system aimed at improving treatment outcomes and reducing surgical replacement frequency for patients with Parkinson’s disease. The company holds several patents related to neurotechnology, artificial intelligence, and neural networks applied to medical devices. No clinical trial results are published; the product is positioned as an improvement over conventional DBS systems in terms of energy efficiency and patient experience

Therapeutic areas: Neurology
Modalities: DeviceNeurostimulation device (Deep brain stimulation system)
Industry: Implantable Medical Devices

Partnerships

NDI Medical/NDI Healthcare Fund (investor/supporter)

Beyond the preview

Go deeper on Deep Brain Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Brain Innovations.

Explore the full profile